BTIG Maintains Buy on Exact Sciences, Lowers Price Target to $80
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Mark Massaro maintains a Buy rating on Exact Sciences (NASDAQ:EXAS), but lowers the price target from $85 to $80.
May 09, 2024 | 7:12 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
BTIG analyst Mark Massaro maintains a Buy rating on Exact Sciences, but lowers the price target from $85 to $80.
The adjustment in price target by BTIG, while maintaining a Buy rating, suggests a positive outlook on the company's fundamentals but with a slightly moderated growth expectation. This could lead to a neutral short-term impact on the stock price as the market digests the new target alongside the continued endorsement of the stock's potential.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100